Lauren P Shapiro1, Elizabeth G Pitts2, Dan C Li2, Britton R Barbee1, Elizabeth A Hinton2, Gary J Bassell3, Christina Gross4, Shannon L Gourley5. 1. Graduate Program in Molecular and Systems Pharmacology, Emory University, Atlanta, Georgia; Yerkes National Primate Research Center, The Robert W. Woodruff Health Sciences Center, Emory University, Atlanta, Georgia; Department of Pediatrics, Emory School of Medicine, Emory University, Atlanta, Georgia. 2. Graduate Program in Neuroscience, Emory University, Atlanta, Georgia; Yerkes National Primate Research Center, The Robert W. Woodruff Health Sciences Center, Emory University, Atlanta, Georgia; Department of Pediatrics, Emory School of Medicine, Emory University, Atlanta, Georgia. 3. Graduate Program in Neuroscience, Emory University, Atlanta, Georgia; Department of Cell Biology, Emory University, Atlanta, Georgia. 4. Division of Neurology, Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio. 5. Graduate Program in Neuroscience, Emory University, Atlanta, Georgia; Yerkes National Primate Research Center, The Robert W. Woodruff Health Sciences Center, Emory University, Atlanta, Georgia; Department of Pediatrics, Emory School of Medicine, Emory University, Atlanta, Georgia; Children's Healthcare of Atlanta, Atlanta, Georgia. Electronic address: shannon.l.gourley@emory.edu.
Abstract
BACKGROUND: The PI3-kinase (PI3K) complex is a well-validated target for mitigating cocaine-elicited sequelae, but pan-PI3K inhibitors are not viable long-term treatment options. The PI3K complex is composed of p110 catalytic and regulatory subunits, which can be individually manipulated for therapeutic purposes. However, this possibility has largely not been explored in behavioral contexts. METHODS: Here, we inhibited PI3K p110β in the medial prefrontal cortex (mPFC) of cocaine-exposed mice. Behavioral models for studying relapse, sensitization, and decision-making biases were paired with protein quantification, RNA sequencing, and cell type-specific chemogenetic manipulation and RNA quantification to determine whether and how inhibiting PI3K p110β confers resilience to cocaine. RESULTS: Viral-mediated PI3K p110β silencing reduced cue-induced reinstatement of cocaine seeking by half, blocked locomotor sensitization, and restored mPFC synaptic marker content after exposure to cocaine. Cocaine blocked the ability of mice to select actions based on their consequences, and p110β inhibition restored this ability. Silencing dopamine D2 receptor-expressing excitatory mPFC neurons mimicked cocaine, impairing goal-seeking behavior, and again, p110β inhibition restored goal-oriented action. We verified the presence of p110β in mPFC neurons projecting to the dorsal striatum and orbitofrontal cortex and found that inhibiting p110β in the mPFC altered the expression of functionally defined gene clusters within the dorsal striatum and not orbitofrontal cortex. CONCLUSIONS: Subunit-selective PI3K silencing potently mitigates drug seeking, sensitization, and decision-making biases after exposure to cocaine. We suggest that inhibiting PI3K p110β provides neuroprotection against cocaine by triggering coordinated corticostriatal adaptations.
BACKGROUND: The PI3-kinase (PI3K) complex is a well-validated target for mitigating cocaine-elicited sequelae, but pan-PI3K inhibitors are not viable long-term treatment options. The PI3K complex is composed of p110 catalytic and regulatory subunits, which can be individually manipulated for therapeutic purposes. However, this possibility has largely not been explored in behavioral contexts. METHODS: Here, we inhibited PI3K p110β in the medial prefrontal cortex (mPFC) of cocaine-exposed mice. Behavioral models for studying relapse, sensitization, and decision-making biases were paired with protein quantification, RNA sequencing, and cell type-specific chemogenetic manipulation and RNA quantification to determine whether and how inhibiting PI3K p110β confers resilience to cocaine. RESULTS: Viral-mediated PI3K p110β silencing reduced cue-induced reinstatement of cocaine seeking by half, blocked locomotor sensitization, and restored mPFC synaptic marker content after exposure to cocaine. Cocaine blocked the ability of mice to select actions based on their consequences, and p110β inhibition restored this ability. Silencing dopamine D2 receptor-expressing excitatory mPFC neurons mimicked cocaine, impairing goal-seeking behavior, and again, p110β inhibition restored goal-oriented action. We verified the presence of p110β in mPFC neurons projecting to the dorsal striatum and orbitofrontal cortex and found that inhibiting p110β in the mPFC altered the expression of functionally defined gene clusters within the dorsal striatum and not orbitofrontal cortex. CONCLUSIONS: Subunit-selective PI3K silencing potently mitigates drug seeking, sensitization, and decision-making biases after exposure to cocaine. We suggest that inhibiting PI3K p110β provides neuroprotection against cocaine by triggering coordinated corticostriatal adaptations.
Authors: Christina Gross; Mika Nakamoto; Xiaodi Yao; Chi-Bun Chan; So Y Yim; Keqiang Ye; Stephen T Warren; Gary J Bassell Journal: J Neurosci Date: 2010-08-11 Impact factor: 6.167